Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes.
RéversibilitéGestion des complications
Facteurs de risque
5
#1
Quels sont les facteurs de risque pour les anomalies des motifs EF Hands ?
Les facteurs incluent des prédispositions génétiques et des expositions environnementales.
Facteurs de risquePrédispositions génétiques
#2
L'âge influence-t-il les motifs EF Hands ?
Oui, le vieillissement peut affecter la fonction des motifs EF Hands et la signalisation calcique.
ÂgeVieillissement
#3
Le mode de vie joue-t-il un rôle dans les risques ?
Un mode de vie sédentaire et une mauvaise alimentation augmentent les risques.
Mode de vieAlimentation
#4
Les antécédents familiaux sont-ils un facteur de risque ?
Oui, des antécédents familiaux de maladies génétiques peuvent augmenter le risque.
Antécédents familiauxMaladies génétiques
#5
Les infections peuvent-elles affecter les motifs EF Hands ?
Certaines infections peuvent perturber la signalisation calcique, affectant ces motifs.
InfectionsSignalisation calcique
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Motifs EF Hands : Questions médicales les plus fréquentes",
"headline": "Motifs EF Hands : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Motifs EF Hands : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-19",
"dateModified": "2025-03-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Motifs EF Hands"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Motifs à hélice-boucle-hélice",
"url": "https://questionsmedicales.fr/mesh/D018257",
"about": {
"@type": "MedicalCondition",
"name": "Motifs à hélice-boucle-hélice",
"code": {
"@type": "MedicalCode",
"code": "D018257",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.500.360"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Motifs EF Hands",
"alternateName": "EF Hand Motifs",
"code": {
"@type": "MedicalCode",
"code": "D020832",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Peter B Stathopulos",
"url": "https://questionsmedicales.fr/author/Peter%20B%20Stathopulos",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada."
}
},
{
"@type": "Person",
"name": "Qi-Tong Lin",
"url": "https://questionsmedicales.fr/author/Qi-Tong%20Lin",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada."
}
},
{
"@type": "Person",
"name": "Biraj B Kayastha",
"url": "https://questionsmedicales.fr/author/Biraj%20B%20Kayastha",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, 74078, USA."
}
},
{
"@type": "Person",
"name": "Aya Kubo",
"url": "https://questionsmedicales.fr/author/Aya%20Kubo",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, 74078, USA."
}
},
{
"@type": "Person",
"name": "Jacob Burch-Konda",
"url": "https://questionsmedicales.fr/author/Jacob%20Burch-Konda",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, 74078, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Role of Transfusion Volume and Transfusion Rate as Markers of Futility During Ultramassive Blood Transfusion in Trauma.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35972167",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/XCS.0000000000000268"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Is whole blood transfusion also an option?]",
"datePublished": "2023-06-05",
"url": "https://questionsmedicales.fr/article/37289852",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Blood transfusion in autoimmune rheumatic diseases.",
"datePublished": "2022-10-28",
"url": "https://questionsmedicales.fr/article/36371394",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.transci.2022.103596"
}
},
{
"@type": "ScholarlyArticle",
"name": "Recommendations for transfusion of blood products in neonatology.",
"datePublished": "2022-06-18",
"url": "https://questionsmedicales.fr/article/35725819",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.anpede.2022.05.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "A prospective assessment of the medic autologous blood transfusion skills for field transfusion preparation.",
"datePublished": "2023-04-17",
"url": "https://questionsmedicales.fr/article/36971031",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/trf.17325"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes chimiques",
"item": "https://questionsmedicales.fr/mesh/D055598"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes biochimiques",
"item": "https://questionsmedicales.fr/mesh/D001669"
},
{
"@type": "ListItem",
"position": 4,
"name": "Conformation moléculaire",
"item": "https://questionsmedicales.fr/mesh/D008968"
},
{
"@type": "ListItem",
"position": 5,
"name": "Conformation des protéines",
"item": "https://questionsmedicales.fr/mesh/D011487"
},
{
"@type": "ListItem",
"position": 6,
"name": "Éléments structuraux des protéines",
"item": "https://questionsmedicales.fr/mesh/D000072416"
},
{
"@type": "ListItem",
"position": 7,
"name": "Motifs à hélice-boucle-hélice",
"item": "https://questionsmedicales.fr/mesh/D018257"
},
{
"@type": "ListItem",
"position": 8,
"name": "Motifs EF Hands",
"item": "https://questionsmedicales.fr/mesh/D020832"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Motifs EF Hands - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Motifs EF Hands",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Motifs EF Hands",
"description": "Comment diagnostiquer un motif EF Hand ?\nQuels tests sont utilisés pour les motifs EF Hands ?\nLes motifs EF Hands sont-ils visibles par imagerie ?\nPeut-on identifier des mutations dans les motifs EF Hands ?\nQuel rôle joue la bioinformatique dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Blood+Transfusion#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Motifs EF Hands",
"description": "Quels symptômes sont associés aux motifs EF Hands ?\nLes motifs EF Hands sont-ils liés à des maladies ?\nComment les motifs EF Hands affectent-ils la signalisation cellulaire ?\nY a-t-il des signes cliniques de dysfonction des motifs EF Hands ?\nLes motifs EF Hands influencent-ils le métabolisme ?",
"url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Blood+Transfusion#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Motifs EF Hands",
"description": "Peut-on prévenir les anomalies des motifs EF Hands ?\nY a-t-il des facteurs environnementaux à considérer ?\nComment le stress influence-t-il les motifs EF Hands ?\nL'exercice physique a-t-il un impact sur ces motifs ?\nLes suppléments de calcium sont-ils bénéfiques ?",
"url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Blood+Transfusion#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Motifs EF Hands",
"description": "Quels traitements ciblent les motifs EF Hands ?\nPeut-on modifier les motifs EF Hands par thérapie génique ?\nLes médicaments peuvent-ils influencer les motifs EF Hands ?\nY a-t-il des approches expérimentales pour traiter les anomalies ?\nComment la nutrition peut-elle influencer les motifs EF Hands ?",
"url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Blood+Transfusion#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Motifs EF Hands",
"description": "Quelles complications peuvent survenir avec des motifs EF Hands défectueux ?\nLes motifs EF Hands sont-ils liés à des cancers ?\nComment les complications affectent-elles la qualité de vie ?\nY a-t-il des risques de maladies cardiovasculaires ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Blood+Transfusion#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Motifs EF Hands",
"description": "Quels sont les facteurs de risque pour les anomalies des motifs EF Hands ?\nL'âge influence-t-il les motifs EF Hands ?\nLe mode de vie joue-t-il un rôle dans les risques ?\nLes antécédents familiaux sont-ils un facteur de risque ?\nLes infections peuvent-elles affecter les motifs EF Hands ?",
"url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Blood+Transfusion#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un motif EF Hand ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des analyses biochimiques et des études de structure protéique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les motifs EF Hands ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la spectroscopie RMN et la cristallographie aux rayons X sont utilisées."
}
},
{
"@type": "Question",
"name": "Les motifs EF Hands sont-ils visibles par imagerie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils nécessitent des méthodes biochimiques pour être étudiés, pas d'imagerie classique."
}
},
{
"@type": "Question",
"name": "Peut-on identifier des mutations dans les motifs EF Hands ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques de séquençage génétique peuvent révéler des mutations affectant ces motifs."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la bioinformatique dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La bioinformatique aide à prédire la structure et la fonction des motifs EF Hands."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux motifs EF Hands ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les motifs EF Hands ne présentent pas de symptômes directs, mais affectent des fonctions cellulaires."
}
},
{
"@type": "Question",
"name": "Les motifs EF Hands sont-ils liés à des maladies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans ces motifs peuvent être associées à des maladies comme l'ataxie."
}
},
{
"@type": "Question",
"name": "Comment les motifs EF Hands affectent-ils la signalisation cellulaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils régulent la signalisation calcique, influençant divers processus cellulaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques de dysfonction des motifs EF Hands ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes indirects peuvent apparaître, comme des troubles neurologiques ou musculaires."
}
},
{
"@type": "Question",
"name": "Les motifs EF Hands influencent-ils le métabolisme ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils jouent un rôle dans le métabolisme cellulaire en régulant le calcium."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies des motifs EF Hands ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques associés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à considérer ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines peut affecter la fonction des motifs EF Hands."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il les motifs EF Hands ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut perturber la signalisation calcique, affectant indirectement ces motifs."
}
},
{
"@type": "Question",
"name": "L'exercice physique a-t-il un impact sur ces motifs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régule la signalisation calcique, ce qui peut soutenir la fonction des motifs."
}
},
{
"@type": "Question",
"name": "Les suppléments de calcium sont-ils bénéfiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments peuvent aider à maintenir un bon équilibre calcique, soutenant la fonction."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les motifs EF Hands ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de traitements spécifiques pour les motifs EF Hands."
}
},
{
"@type": "Question",
"name": "Peut-on modifier les motifs EF Hands par thérapie génique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique pourrait potentiellement corriger des mutations affectant ces motifs."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils influencer les motifs EF Hands ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments modulent la signalisation calcique, indirectement affectant ces motifs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des approches expérimentales pour traiter les anomalies ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur des peptides et des inhibiteurs ciblant les motifs EF Hands."
}
},
{
"@type": "Question",
"name": "Comment la nutrition peut-elle influencer les motifs EF Hands ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une nutrition adéquate en calcium et en magnésium peut soutenir leur fonction."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des motifs EF Hands défectueux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des troubles neurologiques et musculaires."
}
},
{
"@type": "Question",
"name": "Les motifs EF Hands sont-ils liés à des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien potentiel entre des anomalies et certains types de cancer."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des limitations fonctionnelles et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies cardiovasculaires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dysfonctionnements calciques peuvent contribuer à des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies des motifs EF Hands ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des prédispositions génétiques et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les motifs EF Hands ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la fonction des motifs EF Hands et la signalisation calcique."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle dans les risques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une mauvaise alimentation augmentent les risques."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies génétiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles affecter les motifs EF Hands ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent perturber la signalisation calcique, affectant ces motifs."
}
}
]
}
]
}
RG Neuroplasticity, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Leibniz Group 'Dendritic Organelles and Synaptic Function', University Medical Center Hamburg-Eppendorf, Center for Molecular Neurobiology, ZMNH, Hamburg, Germany.
Institute for Biological Instrumentation of the Russian Academy of Sciences, Federal Research Center Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia. epermyak@yandex.ru.
Department of Biomedical Engineering, Pushchino State Institute of Natural Sciences, 142290 Pushchino, Russia. epermyak@yandex.ru.
Using a large national database, we evaluated the relationship between RBC transfusion volume, RBC transfusion rate, and in-hospital mortality to explore the presence of a futility threshold in trauma...
The ACS-TQIP 2013 to 2018 database was analyzed. Adult patients who received ultramassive blood transfusion (≥20 units of RBC/24 hours) were included. RBC transfusion volume and rate were captured at ...
Among 5,135 patients analyzed, in-hospital mortality rate was 62.1% (n = 3,190), and 4-hour and 24-hour mortality rates were 17.53% (n = 900) and 42.41% (n = 2,178), respectively. RBC transfusion volu...
RBC transfusion volume within 4 or 24 hours and mean RBC transfusion rate within 4 hours were not markers of futility. The observed maximum length of survival per mean RBC transfusion rate could infor...
Whole blood is gaining popularity in the treatment of traumatic massive haemorrhage. The prospective study of Hazelton et al. in 2022 shows that mortality is reduced in patients treated with whole blo...
Autoimmune rheumatic disorders (ARD) represent a wide spectrum of disorders that affect in priority the joints, bones, muscles, and connective tissues. Examples of ARD include rheumatoid arthritis, sy...
The scant evidence on the use of transfusions in neonatal care explains the limitations of current clinical guidelines. Despite this, in this document we explore the most recent evidence to make recom...
Data demonstrate the benefit of blood product administration near point-of-injury (POI). Fresh whole blood transfusion from a pre-screened donor provides a source of blood at the POI when resources ar...
We conducted a prospective, observational study of medics with varying levels of experience. Inexperienced medics were those with minimal or no reported experience learning the autologous transfusion ...
The median number of attempts for inexperienced and experienced medics was 1 versus 1 (interquartile range 1-1 for both, p = .260). The inexperienced medics had a slower median time to needle venipunc...
Inexperienced medics have longer procedure times when training autologous whole blood transfusion skills. This data will help establish training measures of performance for skills optimization when le...
Whether clinical practice guidelines have a significant impact on practice is unclear. The effect of guideline recommendations on clinical practice often a lags behind the date of publication. We eval...
RhD-negative blood products are in chronic short supply leading to renewed interest in utilizing RhD-positive blood products for emergency transfusions. This study assessed parental perceptions of eme...
A survey of parents/guardians was conducted on their tolerance of transfusing RhD-positive blood to RhD-negative female children ≤17 years old at four level 1 pediatric hospitals....
In total, 621 parents/guardians were approached of whom 378/621 (61%) completed the survey in its entirety and were included in the analysis. Respondents were mostly females [295/378 (78%)], White [24...
Most parents were willing to accept RhD-positive blood products on behalf of RhD-negative female children in an emergency situation. Further discussions and evidence-based guidelines on transfusing Rh...
Repeated red blood cell (RBC) transfusions in preterm neonates cause the progressive displacement of fetal hemoglobin (HbF) by adult hemoglobin. The ensuing increase of oxygen delivery may result at t...
Blood transfusions are essential to treating anaemia of burn injuries. It has recently been observed that patients with non-major burns < 20%TBSA may also develop anaemia requiring transfusion of bloo...
To determine risk factors for transfusion of blood products in patients with non-major burn injuries and assess transfusion practices to establish impact on patient outcome....
Our study included 182 adult patients with non-major burn injuries, < 20%TBSA admitted over a 3-year period at the Department of Plastic Surgery and Burns Unit of the Emergency County Hospital Cluj-Na...
37.9% of patients included in our study developed anaemia throughout admission and 7.7% underwent blood transfusions. Mean Hb levels triggering blood transfusions have been recorded at 7.4 (IQR=8.8-9....
Patient related comorbidities correlate with higher transfusion rates in non-major burn injuries. Due to the risk associated with the use of blood products decision to transfuse should adhere to curre...
Sc1 is a high-prevalence blood group antigen that is part of the Scianna blood group system. The clinical significance of Scianna antibodies is not well understood because of their rarity; there are o...